


























![]()
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call April 28, 2026 8:30 AM EDT
Company Participants
David DeMartino - Senior Vice President of Investor Relations
Ivan Tornos - President, CEO & Chairman of the Board
Suketu Upadhyay - CFO and Executive VP of Finance, Operations & Supply Chain
Conference Call Participants
Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division
Vijay Kumar - Evercore ISI Institutional Equities, Research Division
Mathew Blackman - TD Cowen, Research Division
Robert Marcus - JPMorgan Chase & Co, Research Division
Travis Steed - BofA Securities, Research Division
Christopher Pasquale - Nephron Research LLC
David Roman - Goldman Sachs Group, Inc., Research Division
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
Matthew Taylor - Jefferies LLC, Research Division
Richard Newitter - Truist Securities, Inc., Research Division
Caitlin Cronin - Canaccord Genuity Corp., Research Division
Matthew Miksic - Barclays Bank PLC, Research Division
Steven Lichtman - William Blair & Company L.L.C., Research Division
Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division
Matthew O'Brien - Piper Sandler & Co., Research Division
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, April 28, 2026. [Operator Instructions] I would now like to turn the conference over to David DeMartino, Senior Vice President, Investor Relations. Please go ahead.
David DeMartino
Senior Vice President of Investor Relations
Thank you, operator, and good morning, everyone. Welcome to Zimmer Biomet's First Quarter 2026 Earnings Conference Call. Joining me on today's call are Ivan Tornos, our Chairman, President and CEO; and Suky Upadhyay, our CFO and EVP, Finance, Operations and Supply Chain. Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties.
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。